HPV Infection and Cervical Abnormalities in HIV Positive Women in Different Regions of Brazil, a Middle-Income Country

Freitas, Beatriz C.G.; Suehiro, Tamy Taianne; Consolaro, Márcia Edilaine Lopes; Silva, Vania Rs

doi:10.7314/apjcp.2015.16.18.8085

Cited by 8 publications

(11 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Lower CD4 count most frequently reported in this review is concordant with previous reviews in which low CD4 was strongly associated with HPV infection [53][54][55]. Previous study also revealed that the most frequent high risk genotype observed in HIV positive women (i.e.…”

Section: Discussionsupporting

confidence: 92%

“…Previous study also revealed that the most frequent high risk genotype observed in HIV positive women (i.e. 46.7%) [54] which is closer to the current pooled estimate for high risk HPV (51.0%), indicating that HIV infection might increase the susceptibility to latent HPV infection [55]. The review conducted to estimate prevalence of HPV genotype among African women, including Ethiopia revealed that HPV16, 52,35,18,58,51,45,31,53, and 56 were the ten most common genotypes in the normal cervical cytology while HPV 16,18,35, and 52 were the four common types [56].…”

Section: Discussionmentioning

confidence: 81%

See 1 more Smart Citation

Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis

Bogale

Belay

Medhin

et al. 2020

Virol J

View full text Add to dashboard Cite

Background Although, there is a variable burden of human papillomavirus (HPV) in women infected with HIV in developing countries, there are few studies that attempted to surmise such variable evidences. This review aimed to estimate the pooled prevalence of HPV genotype distribution and risk factors contributing to HPV infection among women infected with HIV in low- and middle-income countries. Methods We conducted a systematic review and meta-analysis of studies conducted in developing countries and reported HPV prevalence. We searched electronic databases: PubMed/Medline, SCOPUS, ScienceDirect, Excerpta Medical Database from Elsevier, Web of science, Cumulative Index of Nursing and allied Health Sciences and Google scholar databases to retrieve primary studies published in English language till 11th August 2019. We used random-effects model to estimate the pooled prevalence of HPV genotypes, and funnel plot to assess publication bias. The registration number of this review study protocol is CRD42019123549. Results We included nineteen studies with a total of 8,175 participants in this review. The prevalence of HPV was extremely heterogeneous across the studies (χ2= 3782.80, p value < 0.001, I2 = 99.6%). The estimated pooled prevalence of all HPV genotypes was 63.0% (95% CI: 48.0–78.0) while the pooled prevalence of high risk and low risk HPV genotypes were 51.0% (95% CI: 38.0–63.0) and 28.0% (95% CI: 12.0–43.0), respectively. The pooled prevalence of HPV genotype 16 was 20%, while genotype 18 and 52 were 15% and 13%, respectively. Different risk factors reported for HPV infection and the frequently reported were low CD4 count below 200 cells/mm3 and high HIV viral load. Conclusion The pooled prevalence of HPV among HIV infected women in low- and middle-income countries was considerable and the proportion of high risk HPV genotypes were high when compared with low risk genotypes. Therefore, it is essential for the HPV prevention program to prevent the double burden of HPV and HIV in women.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 81%

Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis

Bogale

Belay

Medhin

et al. 2020

Virol J

View full text Add to dashboard Cite

show abstract

“…The incidence and mortality rate are a manifestation of inequality in health, because approximately 85% of the global burden occurs in less developed countries 5 . The HIV/AIDS epidemic also plays an important role in the high incidence of cervical cancer.Previous studies reveal higher rates of HPV in HIV-positive individuals 39,40 .…”

Section: Discussionmentioning

confidence: 99%

Uterus kanser insidansı ve mortalitesi, ve dünyada İnsani Gelişme İndeksi ile ilişkisi

Momenimovahed¹,

Ghoncheh²,

Pakzad³

et al. 2017

Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi)

View full text Add to dashboard Cite

AbstractÖz Purpose: The aim of this study was to evaluate the incidence, mortality of uterine cancer, their relationship with Human Development Index (HDI), and its components in world in 2012. Material and Methods: Data were obtained from incidence and mortality rates presented by GLOBOCAN in 2012. Data on HDI and its components were extracted from the World Bank site. We used the correlation bivariate method for assessment of the correlation between Standardized Mortality Rates (SMRs) and Standardized Incidence Rates with HDI, and its details. Results: In total, 52762 incidence cases and 265672 deaths of prostate cancer were recorded in 2012 in all countries in the world. ASMR for cervix uteri cancer was 6.8 per hundred thousand people in the entire world and ASMR for cervix uteri cancer was 6.8 per hundred thousand people in the entire world.A negative correlation of -0.578 was seen between SIR of uterine cancer and HDI. Also, a negative correlation of -0.717 was seen between SMR of uterine cancer and HDI. Conclusion:The results of this study show that the incidence and mortality of uterine cancer is higher in less developed countries and incidence is positively significantly related to HDI. Finally, the expansion of effective, acceptable screening programs can effectively reduce the incidence of Cancer. Amaç: Bu çalışmanın amacı uterus kanser insidans ve mortalitesinin, İnsani Gelişme Indeksi

show abstract

“…Cancer of the cervix is an AIDS defining condition (Clifford et al, 2006) and women living with HIV infection are known to have an increased prevalence of human papillomavirus (HPV) and an increased prevalence of high risk human papilloma virus (HR-HPV) (Freitas et al, 2015), and a greater likelihood of persistent infections (Beachler et al, 2015) when compared with their human immunodeficiency virus (HIV)-negative counterparts. This is as a result of immunosuppression.…”

Section: Introductionmentioning

confidence: 99%

Sociodemographic determinants of abnormal cervical cytology among HIV positive women in Nnewi, Nigeria

Ugboaja¹,

Oguejiofor²,

Anya³

2017

Int. J. Med. Med. Sci.

View full text Add to dashboard Cite

Women living with human immunodeficiency virus (HIV) infection have a higher burden of premalignant.7, p=0.03) and the Anglicans ( 2 =6.7, p=0.04). The prevalence rate was also the highest among women who were para 0-1 (36.6%), unemployed (100.0%), with no formal education (33.3%), and those who were separated from their husbands (100.0%), but these were not statistically significant. The prevalence of cervical cytological abnormalities among the HIV positive women attending the HIV clinic in NAUTH was high. Younger age, being a trader and Anglican Christian denomination were significantly associated with increased risk of premalignant lesions of the cervix.

show abstract

HPV Infection and Cervical Abnormalities in HIV Positive Women in Different Regions of Brazil, a Middle-Income Country

Cited by 8 publications

References 42 publications

Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis

Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis

Uterus kanser insidansı ve mortalitesi, ve dünyada İnsani Gelişme İndeksi ile ilişkisi

Sociodemographic determinants of abnormal cervical cytology among HIV positive women in Nnewi, Nigeria

Contact Info

Product

Resources

About